Kazuki Sato

Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β

Minako Hoshi, Michio Sato, Shinichiro Matsumoto et al. · Proceedings of the National Academy of Sciences · 2003 · 492 citations · Full text

Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.

Akihiko Takashima, Kei Noguchi, Kazuki Sato et al. · Proceedings of the National Academy of Sciences · 1993 · 380 citations · Full text

Immunology, Cell Death, Neurochemical Biomarkers +16

Erythropoietin Receptor-mediated Inhibition of Exocytotic Glutamate Release Confers Neuroprotection during Chemical Ischemia

Masakatsu Kawakami, Mariko Sekiguchi, Kazuki Sato et al. · Journal of Biological Chemistry · 2001 · 253 citations · Full text

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Vera Bril, Artur Drużdż, Julian Großkreutz et al. · The Lancet Neurology · 2023 · 227 citations

Clinical Trials, Generalised Myasthenia Gravis, Pharmacotherapy +3

The high‐affinity binding of <i>Clostridium botulinum</i> type B neurotoxin to synaptotagmin II associated with gangliosides G_T1b/G_D1a

Tei‐ichi Nishiki, Yoshimi Tokuyama, Y Kamata et al. · FEBS Letters · 1996 · 221 citations